{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:27:48Z","timestamp":1762874868318},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1989,1]]},"DOI":"10.1007\/bf00320230","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T09:09:09Z","timestamp":1098090549000},"page":"15-19","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a"],"prefix":"10.1007","volume":"58","author":[{"given":"A.","family":"Tichelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gratwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"W\ufffdrsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thomssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Holdener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Speck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJM198502143120714","volume":"312","author":"PG Abrams","year":"1985","unstructured":"Abrams PG, Mc Clamrock E, Foon KA (1985) Evening administration of alpha interferon. N Engl J Med 312: 443?444","journal-title":"N Engl J Med"},{"key":"CR2","first-page":"1","volume-title":"Current hematology, vol. 2","author":"DE Bergsagel","year":"1983","unstructured":"Bergsagel DE (1983) Chronic granulocytic leukemia. In: Fairbanks UF (eds) Current hematology, vol. 2. John Wiley and Sons, New York, pp 1?26"},{"key":"CR3","first-page":"29","volume":"8","author":"DE Bergsagel","year":"1986","unstructured":"Bergsagel DE, Haas RH, Messner HA (1986) Interferon alpha-2b in the treatment of chronic granulocytic leukemia. Semin Oncol 8: 29?34","journal-title":"Semin Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","volume":"304","author":"PD Berk","year":"1981","unstructured":"Berk PD, Goldberg JD, Silverstein MN, Weinfeld A, Donovan PB, Ellis JT, Landaw SA, Laszlo J, Najean Y, Pisciotta AV, Wasserman LR (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med 304: 441?447","journal-title":"N Engl J Med"},{"key":"CR5","first-page":"221","volume":"24","author":"H Castro-Malaspina","year":"1982","unstructured":"Castro-Malaspina H, Moore MAS (1982) Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes. Nouv Rev Fr Hematol 24: 221?226","journal-title":"Nouv Rev Fr Hematol"},{"key":"CR6","first-page":"187","volume-title":"Bone marrow disorders","author":"MY Gordon","year":"1985","unstructured":"Gordon MY, Barrett MJ (1985) Chronic myeloid leukaemia and myeloproliferative disorders. In: Gordon MY, Barrett MJ (eds) Bone marrow disorders. Blackwell Scientific Publications, Oxford London Edinburgh Boston Palo Alto Melbourne, pp 187?226"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00633471","volume":"56","author":"R Hehlmann","year":"1988","unstructured":"Hehlmann R, Anger B, Messerer D, Zankovich R, Bergmann L, Kolb HJ, Meyer P, Essers U, Queisser U, Vaupel H, Walther F, Hossfeld DK, Zimmermann R, Heiss F, Mende S, Tigges FJ, Kleeberg UR, Pralle H, Kayser W, Zimmermann R, Tichelli A, Faulhaber JD, R\u00e4th U, Schubert H, Bross K, Schlag R, Schmid L, Weissenfels I, Heinze B, Georgii A, Queisser W, Heimpel H (1988) Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha. Blut 56: 87?91","journal-title":"Blut"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-8703(78)90123-0","volume":"96","author":"S Hussain","year":"1978","unstructured":"Hussain S, Schwartz JM, Friedman SA, Chua SN (1978) Arterial thrombosis in essential thrombocythemia. Am Heart J 96: 31?36","journal-title":"Am Heart J"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-99-4-513","volume":"99","author":"J Jabaily","year":"1983","unstructured":"Jabaily J, Iland HJ, Laszlo J, Massey EW, Faguet GB, Bri\u00e8re J, Landaw SA, Pisciotta AV (1983) Neurologic manifestations of essential thrombocythemia. Ann Intern Med 99: 513?518","journal-title":"Ann Intern Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F","volume":"57","author":"GJ Jones","year":"1986","unstructured":"Jones GJ, Itri LM (1986) Safety and tolerance of recombinant interferon alpha-2a (Roferon-A) in cancer patients. Cancer 57: 1709?1715","journal-title":"Cancer"},{"key":"CR11","first-page":"33","volume":"13","author":"SA Landaw","year":"1976","unstructured":"Landaw SA (1976) Acute leukemia in polycythemia vera. Semin Hematol 13: 33?48","journal-title":"Semin Hematol"},{"key":"CR12","first-page":"156","volume":"23","author":"SA Landaw","year":"1986","unstructured":"Landaw SA (1986) Acute leukemia in polycythemia vera. Semin Hematol 23: 156?165","journal-title":"Semin Hematol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V44.4.483.483","volume":"44","author":"JE Mason","year":"1974","unstructured":"Mason JE, De Vita VT, Canellos GP (1974) Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. Blood 44: 483?487","journal-title":"Blood"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-2008-1068529","volume":"111","author":"N Niederle","year":"1986","unstructured":"Niederle N, Kloke O, Doberauer C, Becher R, Beelen DW, Schmidt CG (1986) alpha-2 Interferon: Erste Behandlungsergebnisse bei der chronischen myeloischen Leuk\u00e4mie. Dtsch Med Wochenschr 111: 767?772","journal-title":"Dtsch Med Wochenschr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.1980.03310100040028","volume":"224","author":"HH Salem","year":"1980","unstructured":"Salem HH, Van der Weyden MB, Kautts J, Firkin BG (1980) Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease. JAMA 224: 1122?1123","journal-title":"JAMA"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","volume":"64","author":"AI Schafer","year":"1984","unstructured":"Schafer AI (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64: 1?12","journal-title":"Blood"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0002-9343(86)90676-5","volume":"80","author":"RT Silver","year":"1986","unstructured":"Silver RT, Gale RP (1986) Chronic myeloid leukemia. Am J Med 80: 1137?1148","journal-title":"Am J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-99-6-789","volume":"99","author":"M Talpaz","year":"1983","unstructured":"Talpaz M, Mavligit G, Keating M, Walters RS, Gutterman JU (1983) Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia. Ann Intern Med 99: 789?792","journal-title":"Ann Intern Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","volume":"314","author":"M Talpaz","year":"1986","unstructured":"Talpaz M, Kantarjian HM, Mc Credie K, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 314: 1065?1069","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V69.5.1280.1280","volume":"69","author":"M Talpaz","year":"1987","unstructured":"Talpaz M, Kantarjian HM, Mc Credie KB, Keating MJ, Trujillo J, Gutterman J (1987) Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 69: 1280?1288","journal-title":"Blood"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0954-6820.1950.tb10111.x","volume":"138","author":"A Videbaek","year":"1950","unstructured":"Videbaek A (1950) Polycythemia vera, course and prognosis. Acta Med Scand 138: 179?187","journal-title":"Acta Med Scand"},{"key":"CR22","unstructured":"Wasserman LR, Goldberg JD, Balcerzak SP, Berk PD, Donovan PB, Dresch C, Ellis JT, Landaw SA, Laszlo J, Mc Intyre OR, Najean Y, Pisciotta AV, Silverstein M, Tartaglia AP, Tatarsky I, Weinfeld A (1981) Influence of therapy on causes of death in polycythemia vera. Clin Res 29: 573 A"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00320230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00320230\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00320230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:45:39Z","timestamp":1585910739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00320230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["BF00320230"],"URL":"https:\/\/doi.org\/10.1007\/bf00320230","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"value":"0006-5242","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}